Then, and only then, will you be able to make an informed and intelligent decision about how and when to use BPC-157 Quick Takeaways No official human clinical dosing guidelines exist for dosing BPC-157 every number you see comes from animal data, community experience, and/or clinician observation over decades 200500 mcg per day is the most commonly used range for subcutaneous injection, with twice-daily dosing favored for acute injuries Earlier administration after injury consistently produces stronger outcomes in animal models, so start using it as soon as possible Long-term human safety data is still absent, but anecdotal evidence looks more promising with each passing day What Is BPC-157
Why Choose Dr
Who funded it, and do they sell the product
Results: Of 1702 patients screened, 811 (420 female [51.8%], median age 77 years [66-84, IQR]) underwent thrombectomy for anterior circulation LVO and were included, of whom 403 (49.7%) received bridging IVT and 693 (85.5%) achieved successful reperfusion (TICI2b)
[DOI] [PMC free article] [PubMed] [Google Scholar] Neilands J
Continuous use without breaks can reduce receptor sensitivity and potentially cause copper dysregulation
